Collaboration aims to develop novel therapeutics, including long-acting semaglutide, using G2GBIO’s proprietary microsphere technology. Samsung Bioepis and Epis NexLab, a sister company operating under Samsung Epis Holdings, have entered into a strategic research collaboration and license agreement with G2GBIO, a…
Infleqtion Delivers the UK’s Only Operational 100-Qubit Quantum Computing System at the National Quantum Computing Centre Infleqtion, a global leader in quantum computing and quantum sensing technologies based on neutral-atom architecture, has reached a significant milestone by delivering the United…
Pivot Bio Launches RETAIN™ Dry, Expanding Application Options for Sorghum Growers Pivot Bio, one of the world’s leading innovative agtech companies, today announced the launch of RETAIN™ Dry, the newest planter box application treatment innovation designed to help sorghum growers…
Argonne-led AI “Adviser” Accelerates Robotic Design of Advanced Electronic Materials A research team led by scientists at the U.S. Department of Energy’s Argonne National Laboratory has developed an innovative artificial intelligence (AI) “adviser” designed to monitor and optimize machine learning…
Mitsubishi Electric Resarchers Elevated to IEEE Fellows in the Class of 2026 Mitsubishi Electric Corporation has announced that two of its distinguished researchers—Dr. Toru Takahashi and Dr. Michael J. Jones—have been elevated to the prestigious grade of IEEE Fellow in…
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development…
A new global initiative by the Pershing Square Foundation recognizes eight pioneering scientists advancing breakthrough research in neuroscience and brain health. The Pershing Square Foundation has announced the eight recipients of the 2026 “MIND” Prize (Maximizing Innovation in Neuroscience Discovery),…
TIXiMED Announces Preclinical Success of Oral TIX100 in Preventing Weight Regain After GLP-1 Therapy TIXiMED, Inc., a clinical-stage pharmaceutical company at the forefront of developing novel therapies targeting metabolic disorders, has released encouraging preclinical data demonstrating the potential of its…
Evox Therapeutics Ltd collaborates with Rett Syndrome Research Trust to evaluate its ExoEdit® exosome-based platform for developing a potential gene editing therapy targeting Rett syndrome. Evox Therapeutics Ltd has announced a new strategic collaboration with the Rett Syndrome Research Trust…